Receptor interactive protein kinase 3 promotes Cisplatin-triggered necrosis in apoptosis-resistant esophageal squamous cell carcinoma cells

scientific article

Receptor interactive protein kinase 3 promotes Cisplatin-triggered necrosis in apoptosis-resistant esophageal squamous cell carcinoma cells is …
instance of (P31):
scholarly articleQ13442814

External links are
P819ADS bibcode2014PLoSO...9j0127X
P356DOI10.1371/JOURNAL.PONE.0100127
P932PMC publication ID4069059
P698PubMed publication ID24959694
P5875ResearchGate publication ID263397273

P50authorLin ZhangQ50942251
P2093author name stringYang Xu
Fang Liu
Qimin Zhan
Nan Zhao
Xiaohang Zhao
Lanping Zhou
Zhengwei Lin
Zbigniew Cichacz
P2860cites workGlobal cancer statisticsQ22241238
Hallmarks of Cancer: The Next GenerationQ22252312
The RIP1/RIP3 necrosome forms a functional amyloid signaling complex required for programmed necrosisQ24293754
RIP1 is required for IAP inhibitor-mediated sensitization of childhood acute leukemia cells to chemotherapy-induced apoptosisQ24299986
Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinaseQ24302381
Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-alphaQ24338113
Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammationQ24338129
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodQ25938999
Global cancer statistics, 2002Q27860562
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resourcesQ27860739
RIP1, a kinase on the crossroads of a cell's decision to live or dieQ28288337
The inhibition of autophagy sensitises colon cancer cells with wild-type p53 but not mutant p53 to topotecan treatmentQ28483781
TNF-induced necroptosis in L929 cells is tightly regulated by multiple TNFR1 complex I and II membersQ28505598
RIP3, an energy metabolism regulator that switches TNF-induced cell death from apoptosis to necrosisQ28594624
Diverse sequence determinants control human and mouse receptor interacting protein 3 (RIP3) and mixed lineage kinase domain-like (MLKL) interaction in necroptotic signalingQ28681792
Molecular mechanisms of necroptosis: an ordered cellular explosionQ29616004
Identification of RIP1 kinase as a specific cellular target of necrostatinsQ29616006
RIP3 mediates the embryonic lethality of caspase-8-deficient miceQ29617723
Molecular mechanisms of caspase regulation during apoptosisQ29617861
Cellular processing of platinum anticancer drugsQ29617899
Is cisplatin-induced cell death always produced by apoptosis?Q34190171
Mixed lineage kinase domain-like is a key receptor interacting protein 3 downstream component of TNF-induced necrosisQ34197341
Signal transduction by tumor necrosis factor and its relativesQ34341941
Identification of a molecular signaling network that regulates a cellular necrotic cell death pathwayQ34910947
Cisplatin biochemical mechanism of action: from cytotoxicity to induction of cell death through interconnections between apoptotic and necrotic pathwaysQ35060995
FADD prevents RIP3-mediated epithelial cell necrosis and chronic intestinal inflammation.Q52614520
TNFR2-mediated apoptosis and necrosis in cisplatin-induced acute renal failure.Q53923667
A role of RIP3-mediated macrophage necrosis in atherosclerosis development.Q54456086
Immunohistochemical study of c-fos-positive lymphocytes infiltrated into human squamous cell carcinomas of the head and neck during radiation therapy and its clinical significanceQ77553809
Role of MRI in osteosarcoma for evaluation and prediction of chemotherapy response: correlation with histological necrosisQ82070785
Use of mixture models in a microarray-based screening procedure for detecting differentially represented yeast mutantsQ83218424
Relationship between hypermethylated MGMT gene and osteosarcoma necrosis rate after chemotherapyQ83674442
Necrotic concentrations of cisplatin activate the apoptotic machinery but inhibit effector caspases and interfere with the execution of apoptosisQ83993352
zVAD-induced necroptosis in L929 cells depends on autocrine production of TNFα mediated by the PKC-MAPKs-AP-1 pathway.Q35092587
Overview of cell death signaling pathwaysQ36051647
Absence of receptor interacting protein kinase 3 prevents ethanol-induced liver injuryQ36774034
Differential regulation of c-Jun protein plays an instrumental role in chemoresistance of cancer cells.Q37000508
Shift from apoptotic to necrotic cell death during human papillomavirus-induced transformation of keratinocytesQ37160973
Anti-apoptotic effects of protein kinase C-delta and c-fos in cisplatin-treated thyroid cells.Q37230815
RIP kinases at the crossroads of cell death and survivalQ37562142
Isolation, characterisation and reconstitution of cell death signalling complexesQ39181693
Smac mimetic LBW242 sensitizes XIAP-overexpressing neuroblastoma cells for TNF-α-independent apoptosisQ39366581
Role of Smac in determining the chemotherapeutic response of esophageal squamous cell carcinoma.Q39523911
Inhibition of apoptosis facilitates necrosis induced by cisplatin in gastric cancer cellsQ40028312
Characterization of 21 newly established esophageal cancer cell linesQ41643714
Involvement of high mobility group B proteins in cisplatin-induced cytotoxicity in squamous cell carcinoma of skin.Q42163245
Heme induces programmed necrosis on macrophages through autocrine TNF and ROS production.Q42176313
Esophageal cancer chemotherapy: recent advances.Q43194164
RIP kinases initiate programmed necrosisQ43292317
Treatment-induced pathologic necrosis: a predictor of local recurrence and survival in patients receiving neoadjuvant therapy for high-grade extremity soft tissue sarcomasQ43658477
Roles of necrosis, Apoptosis, and mitochondrial dysfunction in S-(1,2-dichlorovinyl)-L-cysteine sulfoxide-induced cytotoxicity in primary cultures of human renal proximal tubular cellsQ44355522
The immediate early genes, c-fos, c-jun and AP-1, are early markers of platinum analogue toxicity in human proximal tubular cell primary culturesQ46042108
Significance of necrosis in grading of oligodendroglial neoplasms: a clinicopathologic and genetic study of newly diagnosed high-grade gliomas.Q48352434
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue6
P407language of work or nameEnglishQ1860
P921main subjectesophageal squamous cell carcinomaQ108442577
P304page(s)e100127
P577publication date2014-06-24
P1433published inPLOS OneQ564954
P1476titleReceptor interactive protein kinase 3 promotes Cisplatin-triggered necrosis in apoptosis-resistant esophageal squamous cell carcinoma cells
P478volume9

Reverse relations

cites work (P2860)
Q28608321A Role for Tubular Necroptosis in Cisplatin-Induced AKI
Q34216262A prolyl-hydroxylase inhibitor, ethyl-3,4-dihydroxybenzoate, induces cell autophagy and apoptosis in esophageal squamous cell carcinoma cells via up-regulation of BNIP3 and N-myc downstream-regulated gene-1
Q38799139Cancer and necroptosis: friend or foe?
Q49679681Cell death-based treatments of melanoma:conventional treatments and new therapeutic strategies
Q57809694Comparing the effects of different cell death programs in tumor progression and immunotherapy
Q61814274Differential Mechanisms of Cell Death Induced by HDAC Inhibitor SAHA and MDM2 Inhibitor RG7388 in MCF-7 Cells
Q92645074Effect of the conditional knockout of bone marrow specific RIPK3 gene on bone marrow hematopoiesis in mice
Q61814602Glutathione S-transferase Pi 1 is a valuable predictor for cancer drug resistance in esophageal squamous cell carcinoma
Q96577214Loss of RIPK3 does not impact MYC-driven lymphomagenesis or chemotherapeutic drug-induced killing of malignant lymphoma cells
Q37282991NDRG1 overexpression promotes the progression of esophageal squamous cell carcinoma through modulating Wnt signaling pathway
Q39398933Necroptosis in cancer: An angel or a demon?
Q26739959Necroptosis in tumorigenesis, activation of anti-tumor immunity, and cancer therapy
Q36880241Necroptosis: an alternative cell death program defending against cancer.
Q36210899YM155, a survivin suppressant, triggers PARP-dependent cell death (parthanatos) and inhibits esophageal squamous-cell carcinoma xenografts in mice

Search more.